Delivery Order SPE2DB20D7066-SPE2DB25FC3BF
Award Date
4/16/25
Potential Completion Date
4/17/25
Potential Value
$9.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, identified as SPE2DB22D1017|SPE2DB24FG2YS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,275.86 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the drug CREON DR. The contract has an ultimate completion date of August 12, 2024. Amerisourcebergen, the prime contractor, does not have any set-aside designation for this award. This contract is associated with a...
This federal contract award, with ID SPE2DB20D7066|SPE2DB25FC2UA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,845.94, is for the delivery of 36,000 unit capsules of the product CREON DR. This is a firm fixed-price Delivery Order contract with a completion date of March 28, 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $1,311.87 firm fixed-price delivery order is for the supply of 12,000 unit capsules of the medication CREON DR, with a completion date of July 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB20D2001|SPE2DB25FPMQA, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,144.48 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the drug "CREON DR" with an ultimate completion date of May 6, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This federal contract award, valued at $4,843.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB22D1103|SPE2DB25FTLM9) for the supply of 24,000 unit capsules of the drug Creon DR, with a completion date of May 1, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp is the prime contractor and holds a significant...
This federal contract award, valued at $1,226.88, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 36,000 unit capsules of the medication CREON DR, with a period of performance through May 12, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FR22D, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,617.72 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the medication Creon DR 100s, with a completion date of November 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award, valued at $6,572.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order (SPE2DB20D2104|SPE2DB25FMNSZ) for the supply of 36,000 unit capsules of the medication Creon DR, a product used to treat various gastrointestinal conditions. The contract has a firm fixed-price pricing type and an ultimate completion date of April 17, 2025....
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6MNH, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,572.10 firm fixed-price delivery order is for the supply of 24,000 unit capsules of the drug CREON DR. The contract has a completion date of May 21, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,163.93 firm-fixed-price delivery order is for the supply of 4,564,015,620 units of 24,000-unit capsules of the medication Creon DR. The contract has a period of performance through March 20, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management...